biological source
human plasma
Quality Level
assay
≥95% (SDS-PAGE)
form
solution
packaging
vial of 10 mg protein
technique(s)
cell culture | mammalian: suitable
functional group
ester, phospholipid
shipped in
wet ice
storage temp.
2-8°C
Gene Information
human ... APOB(338), APOC2(344), APOE(348)
Biochem/physiol Actions
高密度脂蛋白（HDL）是胆固醇从血液、组织和器官转运到肝脏的转运剂，在肝脏中胆固醇会分解。 这个过程最终有助于清除动脉胆固醇。HDL俗称“好胆固醇”，占人体总胆固醇的20％-30％。
HDL用于心血管研究和开发潜在的心血管风险管理方法。
HDL用于心血管研究和开发潜在的心血管风险管理方法。
Physical form
含150 mM NaCl和0.01% EDTA的溶液，pH 7.4
Other Notes
Disclaimer
仅供研究使用。本品在法国的科研应用受到监管，包括用于进口和出口活动（法国《公共卫生法典》Public Health Code Article L 1211-1 paragraph 2）。如《公共卫生法典》所述，购买者（即最终用户）需要从法国研究部(France Ministry of Research)获得进口授权。订购此产品即代表您已确认获得合法的进口授权。
Still not finding the right product?
Explore all of our products under 脂蛋白，高密度 来源于人类血浆
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, multi-purpose combination respirator cartridge (US)
商品
Lipoproteins package cholesterol for transport in plasma, essential for lipid transport and cellular function in the body.
由于胆固醇是水不溶性分子，必须包装后才能在血浆中运输。包装胆固醇、胆固醇酯和甘油三酯以便运输的颗粒称为脂蛋白。
Mark J Cziraky et al.
Journal of managed care pharmacy : JMCP, 14(8 Suppl), S3-28 (2009-11-07)
Most clinicians recognize the importance of reducing low-density lipoprotein cholesterol (LDL-C) and, therefore, address this therapeutic need to decrease cardiovascular disease risk. In addition to the critical role that LDL-C plays, recent studies have shown the contribution of other lipid
Kyung-Hyun Cho
Medicines (Basel, Switzerland), 8(7) (2021-08-07)
The composition and properties of apolipoprotein (apo) A-I and apoA-II in high-density lipoproteins (HDL) might be critical to SARS-CoV-2 infection via SR-BI and antiviral activity against COVID-19. HDL containing native apoA-I showed potent antiviral activity, while HDL containing glycated apoA-I
Tisha R Joy
Pharmacology & therapeutics, 135(1), 18-30 (2012-04-03)
Reduction in low-density lipoprotein cholesterol (LDL-C) levels has been associated with a 25-30% reduction in cardiovascular disease risk. However, there still remains a significant and quantifiable risk. Since epidemiologic data have demonstrated that low levels of high-density lipoprotein cholesterol (HDL-C)